(Q43980481)

28 November 2017

title

The role of spironolactone in the treatment of patients with refractory hypertension (English)

1 reference

28 November 2017

0 references

A Michael Lincoff

1 reference

28 November 2017

James Ouzan

1 reference

28 November 2017

Catherine Pérault

series ordinal

1 reference

28 November 2017

Evelyne Carré

series ordinal

1 reference

28 November 2017

Michel Mertes

series ordinal

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Journal of Clinical Hypertension

28 November 2017

published in

1 reference

28 November 2017

1 reference

28 November 2017

issue

4 Pt 1

1 reference

28 November 2017

page(s)

333-339

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Hypertension detection, treatment and control: a call to action for cardiovascular specialists

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

The progression from hypertension to congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Blood pressure and end-stage renal disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Refractory hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Laragh's lessons in pathophysiology and clinical pearls for treating hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

K(+) depletion and the progression of hypertensive disease or heart failure. The pathogenic role of diuretic-induced aldosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Medical management of aldosterone-producing adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

The changing clinical spectrum of primary aldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

Contents of Related Journals

1 reference

https://api.crossref.org/works/10.1016%2FS0895-7061%2801%2902342-1

7 January 2021

10.1016/S0895-7061(01)02342-1

Identifiers

DOI

1 reference

28 November 2017

1 reference